Newsletter Subject

Fw: Just hours left! 🚨

From

cancer.org

Email Address

News@message.cancer.org

Sent On

Thu, Sep 19, 2024 08:36 PM

Email Preheader Text

It’s not too late to make an Impact Drive gift! Dear {NAME}, Did you see the update from this m

It’s not too late to make an Impact Drive gift! [Please Donate Now]( [Display images to show real-time content]( Dear {NAME}, Did you see the update from this morning about our Impact Drive? This effort expires in just a few hours – and we want to make sure you have an opportunity to participate with a gift that supports research, treatments, and crucial services that can change and save lives. [Donate now to make a powerful difference during our Childhood Cancer Awareness Month Impact Drive. >>]( Your gift today helps fund research that is extending lives by supporting: - Drugs to help reduce the risk of relapse of medulloblastomas, one of the most common malignant brain tumors in children - Clinical trials of new treatments for infants with neuroblastoma, showing the promising ability to shrink tumors - Research pinpointing a possible target for preventing the spread of osteosarcoma, a bone cancer that affects teens and young adults - And so much more in the fight against cancer. But we can’t do it without your support! [{NAME}, please make your Impact Drive gift now to help fight cancer before the midnight deadline.]( From all of us at the American Cancer Society and the millions of people whose lives you’ll affect – thank you. --------------------------------------------------------------- [American Cancer Society]( [DONATE]( [Impact Drive Deadline: Tonight]( More than 700 young people in the US are diagnosed with neuroblastoma every year – most of them infants and children under 10. For pediatric cancer patients, this cancer begins in the womb and can quickly cause debilitating symptoms and threaten the youngest lives. But a new treatment is showing promise in early studies by shrinking these types of tumors. Thanks in part to the American Cancer Society’s research, life expectancy for neuroblastoma is increasing, and with your help today, we can help the latest research fast-track lifesaving treatment for this and other cancers. [Donate to our Childhood Cancer Awareness Impact Drive now to power cutting-edge research that saves and improves lives for kids and others facing cancer.]( [GIVE NOW]( [Trial Before and After]( The American Cancer Society recently funded an early phase clinical trial of a new treatment that has shown promise in disrupting a gene that causes neuroblastomas to grow. Pictured above, the images on the left show neuroblastoma tumors circled in red; in the images at right, those same circles are empty following treatment. {NAME}, this is why the American Cancer Society exists – and it’s why your support is SO crucial, and so meaningful. Because when you give, your generosity truly can make groundbreaking, lifesaving research possible. [Please, make your gift to our Impact Drive by MIDNIGHT. Your generosity helps power research, treatment, and breakthroughs that change and save the lives of children and others facing cancer.]( [GIVE NOW]( [Facebook]( [Twitter]( [Instagram]( [Youtube]( [About Us]( | [Legal & Privacy Information]( | [State Fundraising Notices]( | [Give from DAF]( | [Donate]( This email was sent to {EMAIL}. View email as a [web page.]( You can always contact us 24 hours a day, 7 days a week, at 1-800-227-2345 or at [cancer.org/contactus](. American Cancer Society 270 Peachtree Street, Suite 1300 Atlanta, GA, 30303, US Copyright 2024 © American Cancer Society [Unsubscribe](

Marketing emails from cancer.org

View More
Sent On

17/10/2024

Sent On

15/10/2024

Sent On

02/10/2024

Sent On

19/09/2024

Sent On

18/09/2024

Sent On

03/09/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.